Citation 143262

MATSUDA,H: SHIMODA,H: YOSHIKAWA,M:. (1999). STRUCTURE-REQUIREMENTS OF ISOCOUMARINS, PHTHALIDES, AND STILBENES FROM HYDRANGEAE DULCIS FOLIUM FOR INHIBITORY ACTIVITY ON HISTAMINE RELEASE FROM RAT PERITONEAL MAST CELLS.. 7(7)

Citation Details

Title	STRUCTURE-REQUIREMENTS OF ISOCOUMARINS, PHTHALIDES, AND STILBENES FROM HYDRANGEAE DULCIS FOLIUM FOR INHIBITORY ACTIVITY ON HISTAMINE RELEASE FROM RAT PERITONEAL MAST CELLS.
Authors	MATSUDA,H: SHIMODA,H: YOSHIKAWA,M:
Year	1999
Volume	7
Issue	7

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYLLODULCINPHYLLODULCIN-8-O-BETA-D-GLUCOSIDEHYDRANGENOLHYDRANGENOL-4'-O-BETA-D-GLUCOSIDE,(-):HYDRANGENOL-8-O-BETA-D-GLUCOSIDE	INACTIVE
2	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYLLODULCINPHYLLODULCIN-8-O-BETA-D-GLUCOSIDEHYDRANGENOLHYDRANGENOL-4'-O-BETA-D-GLUCOSIDE,(-):HYDRANGENOL-8-O-BETA-D-GLUCOSIDE	INACTIVE
3	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYLLODULCINPHYLLODULCIN-8-O-BETA-D-GLUCOSIDEHYDRANGENOLHYDRANGENOL-4'-O-BETA-D-GLUCOSIDE,(-):HYDRANGENOL-8-O-BETA-D-GLUCOSIDE	INACTIVE
4	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL C	INACTIVE
5	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL C	WEAK ACTIVITY
6	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL C	WEAK ACTIVITY
7	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL D	WEAK ACTIVITY
8	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL D	INACTIVE
9	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL D	INACTIVE
10	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL E	WEAK ACTIVITY
11	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL E	INACTIVE
12	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL E	WEAK ACTIVITY
13	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL G	INACTIVE
14	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL G	INACTIVE
15	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL G	WEAK ACTIVITY
16	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRANGENOL-4'-METHYL ETHER	INACTIVE
17	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRANGENOL-4'-METHYL ETHER	INACTIVE
18	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRANGENOL-4'-METHYL ETHER	INACTIVE
19	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL A	ACTIVE
20	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL A	ACTIVE
21	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL A	WEAK ACTIVITY
22	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL B	WEAK ACTIVITY
23	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL B	WEAK ACTIVITY
24	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL B	ACTIVE
25	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL A,8-DEOXY:	INACTIVE
26	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL A,8-DEOXY:	INACTIVE
27	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL A,8-DEOXY:	INACTIVE
28	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYLLODULCIN,DEHYDRO:	INACTIVE
29	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYLLODULCIN,DEHYDRO:	INACTIVE
30	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYLLODULCIN,DEHYDRO:	ACTIVE
31	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL A,3'-DEOXY:THUNBERGINOL A,3'-8-DEOXY:	INACTIVE
32	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL A,3'-DEOXY:THUNBERGINOL A,3'-8-DEOXY:	INACTIVE
33	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL A,3'-DEOXY:THUNBERGINOL A,3'-8-DEOXY:	INACTIVE
34	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL F	ACTIVE
35	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL F	ACTIVE
36	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THUNBERGINOL F	ACTIVE
37	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRAMACROPHYLLOL AHYDRAMACROPHYLLOL BTHUNBERGINOL F,3'-DEOXY:HYDRANGEAIC ACID	INACTIVE
38	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRAMACROPHYLLOL AHYDRAMACROPHYLLOL BTHUNBERGINOL F,3'-DEOXY:HYDRANGEAIC ACID	INACTIVE
39	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRAMACROPHYLLOL AHYDRAMACROPHYLLOL BTHUNBERGINOL F,3'-DEOXY:HYDRANGEAIC ACID	INACTIVE
40	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRANGEAIC ACID,3'-HYDROXY:	INACTIVE
41	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRANGEAIC ACID,3'-HYDROXY:	ACTIVE
42	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRANGEAIC ACID,3'-HYDROXY:	INACTIVE
43	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRANGENIC ACID,5-HYDROXY:	INACTIVE
44	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRANGENIC ACID,5-HYDROXY:	ACTIVE
45	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYDRANGENIC ACID,5-HYDROXY:	INACTIVE
46	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	INACTIVE
47	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	INACTIVE
48	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL	INACTIVE
49	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PICEATANNOL	WEAK ACTIVITY
50	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PICEATANNOL	ACTIVE
51	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PICEATANNOL	WEAK ACTIVITY
52	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUNULARIN	ACTIVE
53	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUNULARIN	WEAK ACTIVITY
54	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LUNULARIN	ACTIVE
55	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,DIHYDRO:	INACTIVE
56	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,DIHYDRO:	INACTIVE
57	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	RESVERATROL,DIHYDRO:	INACTIVE

Citation 143262

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1